Cellular control of gene expression by T-type cyclin/CDK9 complexes

Gene

Volumn 337, Issue 1-2, 2004, Pages 15-23

  Garriga, Judit ^a   Graña, Xavier ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

7SK snRNA; Cyclin T1; Cyclin T2a; Cyclin T2b; HEXIM1 MAQ1; HIV Tat

Indexed keywords

CYCLIN DEPENDENT KINASE 9; CYCLIN T1; DACTINOMYCIN; HEXAMETHYLENEBISACETAMIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN SUBUNIT; RNA POLYMERASE II; TRANSCRIPTION ELONGATION FACTOR;

BONE MARROW CELL; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; COMPLEX FORMATION; ENZYME ACTIVATION; GENE CONTROL; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC TRANSCRIPTION; HELA CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; REVIEW; RNA SYNTHESIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION INITIATION; ULTRAVIOLET IRRADIATION; VIRUS EXPRESSION;

ANIMALS; CYCLIN-DEPENDENT KINASE 9; CYCLINS; GENE EXPRESSION REGULATION; HUMANS; MODELS, GENETIC; POSITIVE TRANSCRIPTIONAL ELONGATION FACTOR B; PROTEIN BINDING; RNA POLYMERASE II; RNA, SMALL NUCLEAR; TRANSCRIPTION, GENETIC;

EID: 3242769187     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2004.05.007     Document Type: Review

References (80)

1. Abdellatif M., Packer S.E., Michael L.H., Zhang D., Charng M.J., Schneider M.D. A Ras-dependent pathway regulates RNA polymerase II phosphorylation in cardiac myocytes: implications for cardiac hypertrophy. Mol. Cell. Biol. 18:1998;6729-6736
2. Ahn S.H., Kim M., Buratowski S. Phosphorylation of serine 2 within the RNA polymerase II C-terminal domain couples transcription and 3′ end processing. Mol. Cell. 13:2004;67-76
3. Barboric M., Nissen R.M., Kanazawa S., Jabrane-Ferrat N., Peterlin B.M. NF-kappaB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II. Mol. Cell. 8:2001;327-337
4. Bieniasz P.D., Grdina T.A., Bogerd H.P., Cullen B.R. Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat. EMBO J. 17:1998;7056-7065
5. Casse C., Giannoni F., Nguyen V.T., Dubois M.F., Bensaude O. The transcriptional inhibitors, actinomycin D and alpha-amanitin, activate the HIV-1 promoter and favor phosphorylation of the RNA polymerase II C-terminal domain. J. Biol. Chem. 274:1999;16097-16106
6. Chao S.H., Price D.H. Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo. J. Biol. Chem. 276:2001;31793-31799
7. Chao S.H., Fujinaga K., Marion J.E., Taube R., Sausville E.A., Senderowicz A.M., Peterlin B.M., Price D.H. Flavopiridol inhibits P-TEFb and blocks HIV-1 replication. J. Biol. Chem. 275:2000;28345-28348
8. Chen C.M., Kraut N., Groudine M., Weintraub H. I-mf, a novel myogenic repressor, interacts with members of the MyoD family. Cell. 86:1996;731-741
9. Chen R., Yang Z., Zhou Q. Phosphorylated positive transcription elongation factor b (P-TEFb) is tagged for inhibition through association with 7SK snRNA. J. Biol. Chem. 279:2004;4153-4160
10. Chodosh L.A., Fire A., Samuels M., Sharp P.A. 5,6-Dichloro-1-beta-D- ribofuranosylbenzimidazole inhibits transcription elongation by RNA polymerase II in vitro. J. Biol. Chem. 264:1989;2250-2257
11. Cullen B.R. Regulation of HIV gene expression. Aids. 9(Suppl. A):1995;S19-S32
12. Eberhardy S.R., Farnham P.J. c-Myc mediates activation of the cad promoter via a post-RNA polymerase II recruitment mechanism. J. Biol. Chem. 276:2001;48562-48571
13. Eberhardy S.R., Farnham P.J. Myc recruits P-TEFb to mediate the final step in the transcriptional activation of the cad promoter. J. Biol. Chem. 277:2002;40156-40162
14. Fu T.J., Peng J., Lee G., Price D.H., Flores O. Cyclin K functions as a CDK9 regulatory subunit and participates in RNA polymerase II transcription. J. Biol. Chem. 274:1999;34527-34530
15. Fujinaga K., Cujec T.P., Peng J., Garriga J., Price D.H., Graña X., Peterlin B.M. The ability of positive transcription elongation factor b to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat. J. Virol. 72:1998;7154-7159
16. Fujinaga K., Taube R., Wimmer J., Cujec T.P., Peterlin B.M. Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T. Proc. Natl. Acad. Sci. U. S. A. 96:1999;1285-1290
17. Fujinaga K., Irwin D., Huang Y., Taube R., Kurosu T., Peterlin B.M. Dynamics of human immunodeficiency virus transcription: P-TEFb phosphorylates RD and dissociates negative effectors from the transactivation response element. Mol. Cell. Biol. 24:2004;787-795
18. Garber M.E., Wei P., KewalRamani V.N., Mayall T.P., Herrmann C.H., Rice A.P., Littman D.R., Jones K.A. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev. 12:1998;3512-3527
19. Garriga J., Mayol X., Graña X. The CDC2-related kinase PITALRE is the catalytic subunit of active multimeric protein complexes. Biochem. J. 319:1996;293-298
20. Garriga J., Segura E., Mayol X., Grubmeyer C., Graña X. Phosphorylation site specificity of the CDC2-related kinase PITALRE. Biochem. J. 320:1996;983-989
21. Garriga J., Peng J., Parreño M., Price D.H., Henderson E.E., Graña X. Upregulation of cyclin T1/CDK9 complexes during T cell activation. Oncogene. 17:1998;3093-3102
22. Garriga J., Bhattacharya S., Calbo J., Marshall R.M., Truongcao M., Haines D.S., Grana X. CDK9 is constitutively expressed throughout the cell cycle, and its steady-state expression is independent of SKP2. Mol. Cell. Biol. 23:2003;5165-5173
23. Ghose R., Liou L.Y., Herrmann C.H., Rice A.P. Induction of TAK (cyclin T1/P-TEFb) in purified resting CD4(+) T lymphocytes by combination of cytokines. J. Virol. 75:2001;11336-11343
24. Graña X., De Luca A., Sang N., Fu Y., Claudio P.P., Rosenblatt J., Morgan D.O., Giordano A. PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro. Proc. Natl. Acad. Sci. U. S. A. 91:1994;3834-3838
25. Herrmann C.H., Rice A.P. Specific interaction of the human immunodeficiency virus Tat proteins with a cellular protein kinase. Virology. 197:1993;601-608
26. Herrmann C.H., Rice A.P. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor. J. Virol. 69:1995;1612-1620
27. Herrmann C.H., Carroll R.G., Wei P., Jones K.A., Rice A.P. Tat-associated kinase, TAK, activity is regulated by distinct mechanisms in peripheral blood lymphocytes and promonocytic cell lines. J. Virol. 72:1998;9881-9888
28. Hoque M., Young T.M., Lee C.G., Serrero G., Mathews M.B., Pe'ery T. The growth factor granulin interacts with cyclin T1 and modulates P-TEFb-dependent transcription. Mol. Cell. Biol. 23:2003;1688-1702
29. Ivanov D., Kwak Y.T., Nee E., Guo J., Garcia-Martinez L.F., Gaynor R.B. Cyclin T1 domains involved in complex formation with tat and TAR RNA are critical for tat-activation. [In Process Citation] J. Mol. Biol. 288:1999;41-56
30. Ivanov D., Kwak Y.T., Guo J., Gaynor R.B. Domains in the SPT5 protein that modulate its transcriptional regulatory properties. Mol. Cell. Biol. 20:2000;2970-2983
31. Jeffrey P.D. Crystal structure for a cyclin-CDK complex. Trends Cell Biol. 5:1995;391
32. Jones K.A. Taking a new TAK on tat transactivation. Genes Dev. 11:1997;2593-2599
33. Jones K.A., Peterlin B.M. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63:1994;717-743
34. Kanazawa S., Okamoto T., Peterlin B.M. Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection. Immunity. 12:2000;61-70
35. Kanazawa S., Soucek L., Evan G., Okamoto T., Peterlin B.M. c-Myc recruits P-TEFb for transcription, cellular proliferation and apoptosis. Oncogene. 22:2003;5707-5711
36. Kiernan R.E., Emiliani S., Nakayama K., Castro A., Labbe J.C., Lorca T., Nakayama Ki K., Benkirane M. Interaction between cyclin T1 and SCF(SKP2) targets CDK9 for ubiquitination and degradation by the proteasome. Mol. Cell. Biol. 21:2001;7956-7970
37. Kim J.B., Sharp P.A. Positive transcription elongation factor B phosphorylates hSPT5 and RNA polymerase II carboxyl-terminal domain independently of cyclin-dependent kinase-activating kinase. J. Biol. Chem. 276:2001;12317-12323
38. Kim Y.K., Bourgeois C.F., Isel C., Churcher M.J., Karn J. Phosphorylation of the RNA polymerase II carboxyl-terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat-activated transcriptional elongation. Mol. Cell. Biol. 22:2002;4622-4637
39. Koumenis C., Giaccia A. Transformed cells require continuous activity of RNA polymerase II to resist oncogene-induced apoptosis. Mol. Cell. Biol. 17:1997;7306-7316
40. Lam L.T., Pickeral O.K., Peng A.C., Rosenwald A., Hurt E.M., Giltnane J.M., Averett L.M., Zhao H., Davis R.E., Sathyamoorthy M., Wahl L.M., Harris E.D., Mikovits J.A., Monks A.P., Hollingshead M.G., Sausville E.A., Staudt L.M. Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol. Genome Biol. 2:2001;. (RESEARCH0041)
41. Lee D.K., Duan H.O., Chang C. Androgen receptor interacts with positive elongation factor P-TEFb and enhances the efficiency of transcriptional elongation. J. Biol. Chem. 276:2001;9978-9984
42. Lin X., Taube R., Fujinaga K., Peterlin B.M. P-TEFb containing cyclin K and Cdk9 can activate transcription via RNA. J. Biol. Chem. 277:2002;16873-16878
43. Lis J.T., Mason P., Peng J., Price D.H., Werner J. P-TEFb kinase recruitment and function at heat shock loci. Genes Dev. 14:2000;792-803
44. Marshall N.F., Peng J., Xie Z., Price D.H. Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase. J. Biol. Chem. 271:1996;27176-27183
45. Martin-Serrano J., Li K., Bieniasz P.D. Cyclin T1 expression is mediated by a complex and constitutively active promoter and does not limit human immunodeficiency virus type 1 Tat function in unstimulated primary lymphocytes. J. Virol. 76:2002;208-219
46. Michels A.A., Nguyen V.T., Fraldi A., Labas V., Edwards M., Bonnet F., Lania L., Bensaude O. MAQ1 and 7SK RNA interact with CDK9/cyclin T complexes in a transcription-dependent manner. Mol. Cell. Biol. 23:2003;4859-4869
47. Napolitano G., Licciardo P., Gallo P., Majello B., Giordano A., Lania L. The CDK9-associated cyclins T1 and T2 exert opposite effects on HIV-1 Tat activity. Aids. 13:1999;1453-1459
48. Nguyen V.T., Kiss T., Michels A.A., Bensaude O. 7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes. Nature. 414:2001;322-325
49. Ni Z., Schwartz B.E., Werner J., Suarez J.R., Lis J.T. Coordination of transcription, RNA processing, and surveillance by P-TEFb kinase on heat shock genes. Mol. Cell. 13:2004;55-65
50. O'Keeffe B., Fong Y., Chen D., Zhou S., Zhou Q. Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription. J. Biol. Chem. 275:2000;279-287
51. Ouchida R., Kusuhara M., Shimizu N., Hisada T., Makino Y., Morimoto C., Handa H., Ohsuzu F., Tanaka H. Suppression of NF-kappaB-dependent gene expression by a hexamethylene bisacetamide-inducible protein HEXIM1 in human vascular smooth muscle cells. Genes Cells. 8:2003;95-107
52. Peng J., Marshall N.F., Price D.H. Identification of a cyclin subunit required for the function of Drosophila P-TEFb. J. Biol. Chem. 273:1998;13855-13860
53. Peng J., Zhu Y., Milton J.T., Price D.H. Identification of multiple cyclin subunits of human P-TEFb. Genes Dev. 12:1998;755-762
54. Pines J. The cell cycle kinases. [Review]. Semin. Cancer Biol. 5:1994;305-313
55. Ping Y.H., Rana T.M. DSIF and NELF interact with RNA polymerase II elongation complex and HIV-1 Tat stimulates P-TEFb-mediated phosphorylation of RNA polymerase II and DSIF during transcription elongation. J. Biol. Chem. 276:2001;12951-12958
56. Price D.H. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol. Cell. Biol. 20:2000;2629-2634
57. Rechsteiner M., Rogers S.W. PEST sequences and regulation by proteolysis. Trends Biochem. Sci. 21:1996;267-271
58. Renner D.B., Yamaguchi Y., Wada T., Handa H., Price D.H. A highly purified RNA polymerase II elongation control system. J. Biol. Chem. 276:2001;42601-42609
59. Rifkind R.A., Richon V.M., Marks P.A. Induced differentiation, the cell cycle, and the treatment of cancer. Pharmacol. Ther. 69:1996;97-102
60. Sano M., Schneider M.D. Cyclins that don't cycle - cyclin T/cyclin-dependent kinase-9 determines cardiac muscle cell size. Cell Cycle. 2:2003;99-104
61. Sano M., Abdellatif M., Oh H., Xie M., Bagella L., Giordano A., Michael L.H., DeMayo F.J., Schneider M.D. Activation and function of cyclin T-Cdk9 (positive transcription elongation factor-b) in cardiac muscle-cell hypertrophy. Nat. Med. 8:2002;1310-1317
62. Sherr C.J., Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13:1999;1501-1512
63. Shim E.Y., Walker A.K., Shi Y., Blackwell T.K. CDK-9/cyclin T (P-TEFb) is required in two postinitiation pathways for transcription in the C. elegans embryo. Genes Dev. 16:2002;2135-2146
64. Shore S.M., Byers S.A., Maury W., Price D.H. Identification of a novel isoform of Cdk9. Gene. 307:2003;175-182
65. Simone C., Stiegler P., Bagella L., Pucci B., Bellan C., De Falco G., De Luca A., Guanti G., Puri P.L., Giordano A. Activation of MyoD-dependent transcription by cdk9/cyclin T2. Oncogene. 21:2002;4137-4148
66. Spilianakis C., Kretsovali A., Agalioti T., Makatounakis T., Thanos D., Papamatheakis J. CIITA regulates transcription onset viaSer5-phosphorylation of RNA Pol II. EMBO J. 22:2003;5125-5136
67. Taube R., Fujinaga K., Wimmer J., Barboric M., Peterlin B.M. Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation. Virology. 264:1999;245-253
68. Taube R., Lin X., Irwin D., Fujinaga K., Peterlin B.M. Interaction between P-TEFb and the C-terminal domain of RNA polymerase II activates transcriptional elongation from sites upstream or downstream of target genes. Mol. Cell. Biol. 22:2002;321-331
69. Tian Y., Ke S., Chen M., Sheng T. Interactions between the aryl hydrocarbon receptor and P-TEFb. Sequential recruitment of transcription factors and differential phosphorylation of C-terminal domain of RNA polymerase II at cyp1a1 promoter. J. Biol. Chem. 278:2003;44041-44048
70. Wada T., Takagi T., Yamaguchi Y., Watanabe D., Handa H. Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro. EMBO J. 17:1998;7395-7403
71. Wei G.L., Krasinski K., Kearney M., Isner J.M., Walsh K., Andres V. Temporally and spatially coordinated expression of cell cycle regulatory factors after angioplasty. Circ. Res. 80:1997;418-426
72. Wei P., Garber M.E., Fang S.M., Fischer W.H., Jones K.A. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell. 92:1998;451-462
73. Wimmer J., Fujinaga K., Taube R., Cujec T.P., Zhu Y., Peng J., Price D.H., Peterlin B.M. Interactions between Tat and TAR and human immunodeficiency virus replication are facilitated by human cyclin T1 but not cyclins T2a or T2b. Virology. 255:1999;182-189
74. Yamaguchi Y., Takagi T., Wada T., Yano K., Furuya A., Sugimoto S., Hasegawa J., Handa H. NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Cell. 97:1999;41-51
75. Yang X., Gold M.O., Tang D.N., Lewis D.E., Aguilar-Cordova E., Rice A.P., Herrmann C.H. TAK, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines. Proc. Natl. Acad. Sci. U. S. A. 94:1997;12331-12336
76. Yang Z., Zhu Q., Luo K., Zhou Q. The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription. Nature. 414:2001;317-322
77. Yik J.H., Chen R., Nishimura R., Jennings J.L., Link A.J., Zhou Q. Inhibition of P-TEFb (CDK9/Cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA. Mol. Cell. 12:2003;971-982
78. Young T.M., Wang Q., Pe'ery T., Mathews M.B. The human I-mfa domain-containing protein, HIC, interacts with cyclin T1 and modulates P-TEFb-dependent transcription. Mol. Cell. Biol. 23:2003;6373-6384
79. Zhang J., Tamilarasu N., Hwang S., Garber M.E., Huq I., Jones K.A., Rana T.M. HIV-1 TAR RNA enhances the interaction between Tat and cyclin T1. J. Biol. Chem. 275:2000;34314-34319
80. Zhu Y., Pe'ery T., Peng J., Ramanathan Y., Marshall N., Marshall T., Amendt B., Mathews M.B., Price D.H. Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes Dev. 11:1997;2622-2632